Stock OVID OVID THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Ovid Therapeutics Inc.

Equities

OVID

US6904691010

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
3 USD -1.64% Intraday chart for Ovid Therapeutics Inc. -1.96% -6.83%
Apr. 30 B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target MT
Apr. 29 HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
OVID THERAPEUTICS INC. Stock Ovid Therapeutics Inc.
 212M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 109B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
ARGENX SE Stock argenx SE
 22.25B -
BIONTECH SE Stock BioNTech SE
 22.09B -
GENMAB A/S Stock Genmab A/S
 18.68B
  1. Stock Market
  2. Equities
  3. OVID Stock
  4. Charts Ovid Therapeutics Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW